Search results for "Anticoagulation"
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
Apixaban associated with lower adverse event rates than warfarin in frail patients with afib
A retrospective observational study used Medicare data to compare outcomes of apixaban, rivaroxaban, and dabigatran with warfarin in patients with atrial fibrillation.
https://immattersacp.org/weekly/archives/2021/07/20/4.htm
20 Jul 2021
Anticoagulant choice for stroke won't be easy for some time
New agents improve upon warfarin, but they are expensive and lack antidotes for urgent reversal. There is no clear winner among the current options, and more are on the way.
https://immattersacp.org/archives/2013/10/shm.htm
1 Oct 2013
Dabigatran may interact with BP meds in patients with afib and normal kidney function
U.S. guidance currently recommends a lower dabigatran dose in those taking P-glycoprotein inhibitors only if kidney function is impaired.
https://immattersacp.org/weekly/archives/2020/04/28/4.htm
28 Apr 2020
ACP offers free webinar on discussing afib self-management options with patients
The webinar will also cover how to apply risk-scoring systems to determine appropriate anticoagulation based on individual risk of stroke and bleeding.
https://immattersacp.org/weekly/archives/2018/11/06/2.htm
6 Nov 2018
Dual therapy for afib after PCI may reduce bleeding risk better than triple therapy
Researchers reviewed four randomized controlled trials of 7,953 patients that compared the effects of dual versus triple therapy on bleeding, mortality, and ischemic events after percutaneous coronary intervention (PCI).
https://immattersacp.org/weekly/archives/2020/03/17/4.htm
17 Mar 2020
Updated guidelines released on antithrombotic therapy for afib
The American College of Chest Physicians provided 60 recommendation statements in the areas of stroke risk, bleeding risk, antithrombotic therapy, and management of bleeding on oral anticoagulation, among other topics.
https://immattersacp.org/weekly/archives/2018/08/28/2.htm
28 Aug 2018
Anticoagulants compared for associated risk of hospitalization due to upper GI bleeding
Proton-pump inhibitor cotherapy significantly reduced risk among patients on anticoagulation, a cohort study found.
https://immattersacp.org/weekly/archives/2018/12/11/4.htm
11 Dec 2018
MKSAP Quiz: INR management
A 61-year-old woman undergoes routine evaluation. She reports no recent changes in her medications. She has a history of idiopathic deep venous thrombosis. Her only medication is warfarin, initiated 2 months ago. Following a physical exam and international normalized ratio (INR) measurement of 7.2, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2020/07/28/3.htm
28 Jul 2020
NOACs recommended instead of warfarin for some afib patients, guideline states
An updated guideline on atrial fibrillation responds to new evidence, as well as the advent of new drugs and devices to treat the condition.
https://immattersacp.org/weekly/archives/2019/02/05/2.htm
5 Feb 2019